Only 41.3% of patients with incidentally detected lung nodules receive recommended follow-up imaging at two New York City hospitals, according to a study published on October 28 in BMC Pulmonary Medicine, leaving a majority of potentially malignant findings unmonitored and exposing critical healthcare disparities.
In Plain English: The Clinical Takeaway
- Incidental Lung Nodules (ILNs): Small spots discovered on routine scans performed for other health issues. Approximately 1.6 million are found annually in the U.S., with up to 6% representing early-stage lung cancer.
- Surveillance Gaps: Over 60% of patients fail to complete the follow-up computerized tomography (CT) scans recommended by radiologists to determine if a nodule is growing or changing.
- Vulnerable Populations: Uninsured individuals, Medicaid beneficiaries, and specific racial minorities experience significantly lower completion rates, compounding risks for delayed diagnoses.
Uncovering Surveillance Gaps at Mount Sinai Hospitals
Researchers at Mount Sinai Morningside and Mount Sinai West analyzed surveillance adherence for incidentally detected lung nodules in a racially and socioeconomically diverse urban population, as reported by AuntMinnie. The study utilized natural language processing software to scan radiology reports from January to June 2022. Out of 3,925 flagged reports, 1,266 patients met the inclusion criteria, with chest CT accounting for 84.1% of the examinations.
Bioengineer.org reported that the cohort had a median age of 70 years, with 57.5% female participants. The racial distribution of the study group included White patients at 43.4%, Black patients at 22.5%, Asian patients at 5.4%, and patients categorized as Other race at 26.1%, with 2.6% unrecorded. Among the 41.3% of patients who successfully completed their follow-up imaging, 5.7% were diagnosed with lung cancer, highlighting the vital necessity of strict adherence to surveillance protocols.
Demographic and Structural Barriers to Follow-Up Imaging
Statistical models within the study isolated clear demographic and structural factors influencing whether a patient receives timely surveillance. In fully adjusted integrated models, Black patients and those in the Other race category demonstrated persistently lower odds of completing follow-up, with adjusted odds ratios of 0.774 and 0.779 respectively. Insurance status played an equally decisive role in patient outcomes.
Uninsured individuals exhibited significantly reduced odds of completing recommended imaging, showing an odds ratio of 0.461 compared to insured patients. Medicaid beneficiaries faced similar hurdles, with an odds ratio of 0.718. Furthermore, the physical setting where the initial scan took place altered patient trajectories drastically. Imaging obtained in hospital emergency departments independently lowered follow-up odds to 0.451, while inpatient admissions reduced follow-up odds to 0.531. Conversely, scans performed during standard working hours and documented emphysema diagnoses correlated with higher adherence rates.
| Demographic or Clinical Variable | Statistical Association (Odds Ratios) | Clinical Impact on Surveillance |
|---|---|---|
| Uninsured Status | OR: 0.461 | Significantly reduced likelihood of completing follow-up imaging. |
| Emergency Department Setting | aOR: 0.451 | Independently lowers odds of tracking incidental findings. |
| Inpatient Admission Setting | aOR: 0.531 | Reduces probability of outpatient surveillance compliance. |
| Medicaid Coverage | OR: 0.718 | Lowered odds compared to commercial or other insurance types. |
| Black Patient Cohort | aOR: 0.774 | Persistently lower odds of finishing recommended surveillance. |
Contraindications & When to Consult a Doctor
While surveillance imaging for incidental lung nodules carries no direct physiological contraindications, clinicians must weigh the cumulative risks of ionizing radiation and patient anxiety against the clinical suspicion of malignancy. Patients with severe comorbidities or limited life expectancy where aggressive cancer treatment is not indicated may be excused from rigorous follow-up protocols.
Individuals who receive radiology reports mentioning incidental nodules—especially those with a history of smoking, chronic obstructive pulmonary disease (COPD), or emphysema—must consult a primary care physician or pulmonologist immediately. Symptoms such as persistent cough, unexplained weight loss, hemoptysis (coughing up blood), or new chest pain warrant prompt clinical evaluation regardless of scheduled surveillance intervals.
Pathways Forward for Urban Health Systems
The authors of the study emphasize that targeted structural interventions are mandatory to bridge these persistent healthcare gaps. Implementing automated tracking systems, dedicated patient navigation programs, and standardized reporting protocols can streamline communication between radiologists, emergency departments, and outpatient providers. By addressing socioeconomic hurdles head-on, medical centers can ensure that incidental findings do not translate into missed opportunities for early cancer intervention.
References
- Wang, H. Y., et al. (2026). Evaluation of follow-up adherence for incidentally detected lung nodules in an urban hospital system. BMC Pulmonary Medicine.
- AuntMinnie. Coverage of incidental lung nodule surveillance study from Mount Sinai Morningside and Mount Sinai West.
- Bioengineer.org. Reporting on demographic variables and multivariable models in pulmonary nodule tracking research.
Disclaimer: This article is for informational purposes only and does not substitute for professional medical advice, diagnosis, or treatment.
